• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Presenting on Emerging Growth Conference 81 Day 1 on April 16; Register to live stream

    4/15/25 7:00:00 AM ET
    $ASBP
    $BENF
    $BNZI
    $CIA
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Finance: Consumer Services
    Finance
    Get the next $ASBP alert in real time by email

    MIAMI, April 15, 2025 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 81th Emerging Growth Conference on April 16 & 17, 2025.

    The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    For updates, follow us on Twitter

    Day 1

    April 16, 2025

    9:00

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:20

    Introduction

    9:25 – 9:35

    Empire Energy (ASX: EEG)

    Keynote speaker: Alex Underwood, CEO & Managing Director

    9:40 – 10:10

    PSQ Holdings, INc. (NYSE:PSQH)

    Keynote speaker: Michael Seifert, Founder, President / CEO

    10:50 – 11:20

    Ur-Energy (NYSE:URG) (TSX:URE)

    Keynote speaker: John W. Cash, CEO

    11:25 - 11:55

    Interstellar Communication Holdings

    Keynote speakers: Seda Hewitt, Space Ambassador of IcMercury Harri Laitinen, Lifeguard of IcMercury, and Lijie Zhu, Captain of icMercury

    12:00 – 12:30

    U.S. Energy Corporation (NASDAQ:USEG)

    Keynote speaker: Ryan Smith, President, CEO & Director

    12:35 – 1:05

    Odyssey Marine Exploration, Inc. (NASDAQ:OMEX)

    Keynote speaker: Mark D. Gordon, Chairman & CEO

    1:10 – 1:40

    Nova Minerals Limited (NASDAQ:NVA) (ASX: NVA)

    Keynote speaker: Christopher Gerteisen – CEO & Executive Director

    1:45 – 2:15

    C3 Metals Inc. (TSXV:CCCM) (OTCQB:CUAUF)

    Keynote speaker: Daniel A. Symons, President, CEO & Director

    2:20 – 2:50

    Ucore Rare Metals, Inc. (OTCQX:UURAF) (TSXV:UCU)

    Keynote speakers: Pat Ryan, CEO

    2:55 – 3:05

    Eloro Resources, Ltd. (OTCQX:ELRRF) (TSX:ELO)

    Keynote speakers: Chris Holden – VP Corporate Development

    3:10 - 3:20

    Opawica Explorations Inc. (OTCQB:OPWEF) (TSXV:OPW)

    Keynote speaker: Blake Morgan, President / CEO

    3:25 - 3:35

    HydroGraph Clean Power Inc. (OTCQB:HGRAF) (CSE:HG)

    Keynote speaker: Kjirstin Breure, President and CEO

    Postponed

    GeoVax Labs, Inc. (NASDAQ:GOVX)

    Keynote speakers: David Dodd, Chairman, President / CEO

    _______________________________________________________________

    Day 2

    April 17, 2025

    8:45

    Virtual Lobby opens.

    Register for the Conference. If you already registered, go back to the registration link and click "Already registered" and enter your email.

    9:00

    Introduction

    9:05 – 9:35

    SBC Medical Group Holdings, Inc. (NASDAQ:SBC)

    Keynote speaker: Yuya Yoshida, Executive Vice President & CFO

    10:50 – 11:20

    Evofem Biosciences, Inc. (OTCQB:EVFM)

    Keynote speaker: Amy Raskopf, Chief Business Development Officer

    11:25 – 11:55

    Bioxytran, Inc. (OTCQB:BIXT)

    Keynote speakers: Dr. David Platt, CEO & Mike Sheikh, Executive Vice President Business Development

    12:00 – 12:30

    Clene Inc., (NASDAQ:CLNN)

    Keynote speakers: Rob Etherington, President / CEO

    12:35 – 1:05

    Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP)

    Keynote speakers: Kraig Higginson – CEO

    1:10 – 1:40

    Regen BioPharma Inc. (OTC:RGBP)

    Keynote speakers: David Koos, President / CEO, & Harry M. Lander, Ph.D. Senior Scientific Consultant

    1:45 - 2:15

    Banzai International, Inc. (NASDAQ:BNZI)

    Keynote speaker: Joseph Davy, Co-Founder, Chairman & CEO

    2:55 – 3:05

    Citizens, Inc. (NYSE:CIA)

    Keynote speakers: Jon Stenberg, President / CEO, and Jeff Conklin, CFO

    3:10 - 3:20

    Sono Group N.V. (OTCQB:SEVCF)

    Keynote speaker: George O'Leary, Managing Director, CEO and CFO

    Postponed

    22nd Century Group, Inc. (NASDAQ:XXII)

    Keynote speaker: Lawrence D. Firestone, Chairman & CEO

    3:40 – 3:50

    Alt Equity

    Keynote speaker: Daniel Wait, President / Founder

    3:55 – 4:05

    Cyios Corp. (OTC:CYIO)

    Keynote speaker: John O'Shea, Chairman

    4:10 – 4:20

    Beneficient (NASDAQ:BENF)

    Keynote speaker: Brad K. Heppner, CEO

    Visit the following link to register. You will then receive an email containing the link and time to sign into the conference.

    Register for the Conference here.

    Submit Questions for any of the presenting companies to:

    [email protected]

    Replays: Subscribe to our YouTube Channel

    About EmergingGrowth.com

    Founded in 2009, Emerging Growth.com quickly became a leader in its space and has developed an extensive history of identifying emerging growth companies that can be overlooked by the investment community.

    About the Emerging Growth Conference

    The Emerging Growth Conference is an effective way for public companies to engage with the investment community regarding their Company, new products, services and other major announcements from anywhere, in an effective and time efficient manner.

    All sessions are conducted through video webcasts. Our conference serves as a vehicle for Emerging Growth to build relationships with our existing and potential clients. Accordingly, a certain number of the presenting companies are our current clients, and some may become our clients in the future. In exchange for services we provide, our clients pay us fees in the form of cash and securities, and we may currently have, or in the future may have investments in the securities of certain of the presenting companies. Finally, certain of the presenting companies have paid us a fee to secure a presentation time slot or to present generally. The presentations to be delivered by the presenting companies (including any virtual handouts of written materials) have not been approved, endorsed by or otherwise reviewed by EmergingGrowth.com nor should they in any way be construed to have been made in connection with an offer to sell or a solicitation of an offer to buy securities. Please consult an investment professional before investing in anything viewed on the Emerging Growth Conference or on EmergingGrowth.com.

    If you believe or know of a company that might fit our audience, contact us here.

    Thank you for your interest in our conference, and we look forward to your participation in future conferences.

    Contact:

    Emerging Growth

    Phone: 1-305-330-1985

    Email: [email protected]



    Primary Logo

    Get the next $ASBP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASBP
    $BENF
    $BNZI
    $CIA

    CompanyDatePrice TargetRatingAnalyst
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Ur Energy Inc
    $URG
    10/27/2025$2.15Outperform
    Northland Capital
    Ur Energy Inc
    $URG
    7/25/2025$3.00Buy
    Maxim Group
    Ur Energy Inc
    $URG
    7/23/2025$2.00Buy
    B. Riley Securities
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$18.00 → $14.00Buy
    D. Boral Capital
    GeoVax Labs Inc.
    $GOVX
    4/15/2025$15.00 → $8.50Buy
    Alliance Global Partners
    PSQ Holdings Inc.
    $PSQH
    1/15/2025$8.00Buy
    Maxim Group
    GeoVax Labs Inc.
    $GOVX
    11/11/2024$15.00Buy
    Alliance Global Partners
    More analyst ratings

    $ASBP
    $BENF
    $BNZI
    $CIA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Northland Capital initiated coverage on Ur-Energy with a new price target

    Northland Capital initiated coverage of Ur-Energy with a rating of Outperform and set a new price target of $2.15

    10/27/25 8:50:37 AM ET
    $URG
    Precious Metals
    Basic Materials

    Maxim Group initiated coverage on Ur-Energy with a new price target

    Maxim Group initiated coverage of Ur-Energy with a rating of Buy and set a new price target of $3.00

    7/25/25 8:21:07 AM ET
    $URG
    Precious Metals
    Basic Materials

    $ASBP
    $BENF
    $BNZI
    $CIA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    SEC Filings

    View All

    22nd Century Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits

    8-K - 22nd Century Group, Inc. (0001347858) (Filer)

    2/20/26 4:15:28 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 424B3 filed by Beneficient

    424B3 - Beneficient (0001775734) (Filer)

    2/18/26 6:05:49 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    SEC Form 10-Q filed by Beneficient

    10-Q - Beneficient (0001775734) (Filer)

    2/17/26 5:21:51 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matlin David J bought $216,664 worth of shares (33,333 units at $6.50), increasing direct ownership by 7% to 477,824 units (SEC Form 4)

    4 - Clene Inc. (0001822791) (Issuer)

    1/13/26 2:48:54 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Seifert Michael Stephen bought $10,000 worth of shares (7,143 units at $1.40), increasing direct ownership by 6% to 133,955 units (SEC Form 4)

    4 - PSQ Holdings, Inc. (0001847064) (Issuer)

    12/1/25 7:10:54 PM ET
    $PSQH
    Advertising
    Consumer Discretionary

    VICE PRESIDENT FINANCE Walle Jade bought $182,880 worth of shares (144,000 units at $1.27) (SEC Form 4)

    4 - UR-ENERGY INC (0001375205) (Issuer)

    11/21/25 5:06:49 PM ET
    $URG
    Precious Metals
    Basic Materials

    $ASBP
    $BENF
    $BNZI
    $CIA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Mclaughlin Vallerie

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:57 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Wilcox Reed N

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:05:22 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Director Mosca Alison

    4 - Clene Inc. (0001822791) (Issuer)

    2/20/26 4:04:47 PM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Clene to Present at the Emerging Growth Conference

    SALT LAKE CITY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ:CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced that management will present at the Emerging Growth Conference. Virtual Presentation DetailsDate: February 25, 2026Time of Presentation: 1:45 p.m. ETFormat: Corporate update A webcast of the presentation will be available on the "Events" section of the Clene website. Alternative

    2/19/26 8:30:00 AM ET
    $CLNN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Beneficient Reports Third Quarter Fiscal 2026 Results

    DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 third quarter, which ended December 31, 2025. Highlights of the quarter include: Resolved GWG Holdings, Inc. litigation and regained Nasdaq complianceGenerated $50 million in gross proceeds from asset salesFully paid off HH-BDH Credit Agreement principal balance (excluding $1.7 million for deferred interest and fees)Strengthened balance sheet and collateral base Commenting on the

    2/17/26 5:00:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    $ASBP
    $BENF
    $BNZI
    $CIA
    Leadership Updates

    Live Leadership Updates

    View All

    PublicSquare Appoints Dusty Wunderlich as Chief Executive Officer

    New Leadership Reinforces Progress Toward Fintech Focus PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company"), today announced that Dusty Wunderlich has been appointed CEO, effective immediately, as the Company continues its transition to core fintech businesses, including credit and payments. Mr Wunderlich was recently appointed Chairman of the Board of PublicSquare and will remain in that role. As part of this transition, Michael Seifert has stepped down as Chief Executive Officer and resigned from the Company's Board of Directors, effective January 27, 2026. Mr. Wunderlich was CEO of Credova until PublicSquare acquired the company in March 2024. Given his fintech experienc

    1/29/26 7:30:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Beneficient Appoints Peter T. Cangany Jr. as Chairman of the Board

    DALLAS, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today announced that its Board of Directors (the "Board") has appointed Peter T. Cangany Jr. as Chairman of the Board, effective December 15, 2025. Mr. Cangany has served as a director of Beneficient and as Chairman of its independent Audit Committee since 2019. He brings decades of leadership experience in financial reporting, accounting, and corporate governance within the financial services industry. Mr. Cangany retired as a partner

    12/17/25 7:30:00 AM ET
    $BENF
    Finance: Consumer Services
    Finance

    PublicSquare to Host Virtual Analyst & Investor Day on Thursday, September 25, 2025

    PSQ Holdings, Inc. (NYSE:PSQH) ("PublicSquare" or the "Company") announced today that the Company will host a virtual analyst and investor day on Thursday, September 25, 2025 from 11:00 a.m. ET to 1:00 p.m. ET. The Company will post slides and other supporting material to its website on the day of the event. Michael Siefert, Chief Executive Officer, Dusty Wunderlich, Chief Strategy Officer and other members of the executive leadership team will discuss strategic fintech initiatives, long-term plans related to digital assets, and business outlook followed by an interactive question-and-answer session. The analyst and investor day will be broadcast live through a link on the PublicSquare

    9/3/25 7:00:00 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    $ASBP
    $BENF
    $BNZI
    $CIA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by PSQ Holdings Inc.

    SC 13G - PSQ Holdings, Inc. (0001847064) (Subject)

    12/12/24 11:50:43 AM ET
    $PSQH
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    11/14/24 5:56:57 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ASBP
    $BENF
    $BNZI
    $CIA
    Financials

    Live finance-specific insights

    View All

    22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results

    Balance sheet strength, ended 2025 with $7.1 million in cash and debt free, supports transition to growth Continued VLN® commercial expansion drives shift toward higher margin proprietary branded products MOCKSVILLE, N.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), the only tobacco products company that has for 27 years led and continues to lead the fight against the harms of smoking driven by nicotine addiction, today announced select, preliminary and unaudited financial results and operating metrics for the fourth quarter and full year ended December 31, 2025. The company anticipates releasing fourth quarter and full year 2025 earnings on or before March

    2/20/26 4:15:00 PM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Beneficient Reports Third Quarter Fiscal 2026 Results

    DALLAS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ:BENF) ("Ben" or the "Company"), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets, today reported its financial results for the fiscal 2026 third quarter, which ended December 31, 2025. Highlights of the quarter include: Resolved GWG Holdings, Inc. litigation and regained Nasdaq complianceGenerated $50 million in gross proceeds from asset salesFully paid off HH-BDH Credit Agreement principal balance (excluding $1.7 million for deferred interest and fees)Strengthened balance sheet and collateral base Commenting on the

    2/17/26 5:00:00 PM ET
    $BENF
    Finance: Consumer Services
    Finance

    Noble Plains Uranium Acquires Historical Drill Data For 1,211 Holes On Shirley Central Project in Wyoming

    Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Noble Plains Uranium Corp. (TSXV:NOBL) (OTCQB:NBLXF) (FSE: INE0) ("Noble Plains" or the "Company") a U.S. focused uranium exploration and development company, is pleased to announce it has entered into a data acquisition agreement with Pathfinder Mines Corporation ("Pathfinder"), a wholly owned subsidiary of Ur-Energy Inc. (TSX:URE) (NYSE:URG), to acquire the historical database for 1,211 drill holes located on Noble Plains' Shirley Central Project ("Shirley Central" or the "Project") in Wyoming's past-producing Shirley Basin.This high-quality dataset includes lithologic logs, geophysical results and historical interpretatio

    12/18/25 7:30:00 AM ET
    $URG
    Precious Metals
    Basic Materials